Good day. And welcome to the Healthcare Trust of America Third Quarter 2019 Earnings Conference Call and Webcast. All participants will be in listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded. I will now turn the call over to David Gershenson, Chief Accounting Officer.

Thank you. And welcome to Healthcare Trust of America's third quarter 2019 earnings call. We filed our earnings release and our financial supplement yesterday after the close. These documents can be found on the Investor Relations section of our website or with the SEC.Please note, this call is being webcast and will be available for replay for the next 90 days. We will be happy to take your questions at the conclusion of our prepared remarks. During the course of the call, we will be making forward-looking statements. These forward-looking statements are based on the current beliefs of management, and information currently available to us. Our actual results will be affected by known and unknown risks, trends, uncertainties and factors that are beyond our control or ability to predict. Although, we believe that our assumptions are reasonable, they are not guarantees of future performance. Therefore, our actual future results could materially differ from our current expectations. For a detailed description on potential risks, please refer to our SEC filings, which can be found in the Investor Relations section of our website.I will now turn the call over to Scott Peters, Chairman and CEO of Healthcare Trust of America. Scott?

Thank you, David. And good morning, and thank you for joining us today for Healthcare Trust of America's third quarter earnings conference call. Joining me on the call today are Robert Milligan, our Chief Financial Officer; Amanda Houghton, our Executive Vice President of Asset Management; and Caroline Chiodo, our Senior Vice President of Acquisitions and Development.As we move into the end of 2019 and look forward to 2020, HTA has positioned itself to be the sector leader in the ownership and operation of medical office buildings. With an irreplaceable key market focused portfolio, a fully integrated, full service operating platform and a fortress investment grade balance sheet that positions our company to deliver earnings growth and shareholder returns over the next three years to five years. We have talked for years about our view of the overwhelming trends in healthcare that reflect a move to an integrated outpatient experience. This delivery will take place in three settings. One, on-campus where we are the largest owner of MOBs in the country. Two, off-campus in the community locations where all leading healthcare providers are focusing. And three, in academic university healthcare system locations, where academic and healthcare combinations are critical.Our portfolio composition over the last 12 years has referred to these trends and a critical nature of this real estate, where the best assets in each location demonstrate high levels of tenant retention and rental growth opportunities. Our portfolio and investment strategy has reflected these key trends and HTA has targeted key fast growing market that we believe will outperform the rest of the country.Our targeted market approach also allows us to create size and scaling markets, with 15 markets with over 500,000 square feet and nine markets with approximately 1 million square feet or more square feet. This scale allows us…

Thanks, Scott. Our team continues to focus on delivering high quality operating and leasing performance that bring value to tenants and shareholders alike. As we look forward into the coming quarters, we believe our greatest opportunities to add value are, one, leveraging our size, scale and in-house infrastructure to maximize efficiencies within our markets, and deepen relationships with our existing tenant base.Our team is now close to 200 property management, building management construction and leasing professionals, span across 23 offices and directly interface with the vast majority of our tenant base. We believe our infrastructure, not only allows us to bring the power of a national company to a very local healthcare provider community, but also helps us generate strong local knowledge, relationships and capabilities that have resulted in high levels of same-store growth, sector-leading operating efficiencies, strong leasing and retention, and also great opportunities for acquisition and our development.Two, continued focus on executing quality leases with strong tenants at rental rates and escalators, that reflects the quality of our buildings and locations and will translate to long-term cash flow growth for our shareholders. And three strategic investments in our markets and buildings that will maximize rate, tenant retention, and efficiencies in our operations. However, we will continue to be strategic in our use of capital in an effort to maximize returns.Turning now to the third quarter, our same-store growth this quarter came in at 2.5% driven by a 2% base revenue growth and 50 basis points of rental margin expansion. In the period, we signed approximately 700,000 square feet of leases. This included 156,000 square feet of new leases and almost 540,000 square feet of renewals. Our total tenant retention for same-store portfolio was 86% while our total portfolio re-leasing spreads remained strong at 2.7%.Our annual escalators for leases…

Thanks, Amanda. We will now turn the call over for the first time to Caroline Chiodo, our Senior Vice President of Acquisitions and Developments to discuss the current state of the market and the opportunities we are seeing. Caroline joined us almost two years ago from Duff & Phelps Investment Management and has brought a unique view and perspective to our investment philosophy. Caroline?

Thanks, Robert. From an investment perspective, we've experienced an uptick in activity in 2019. With the increase in opportunities, we remain disciplined in our capital allocation, where we are focused on quality assets in our key markets. We continue to target 15 to 25 key markets with the goal to increase our share to at least 1 million square feet in [indiscernible] market.As we increase our geographic concentration, we gain brand relevancy with health system, academic universities, and large physicians' groups. In addition, we improved operational efficiencies as we leverage them to platform. It is important to note this geographic concentration cannot be easily replicated, and more importantly, this platform generates significant local knowledge. This local expertise has a competitive advantage and improved underwriting and in addition allows us to source a significant number of off-market transactions within these targeted markets. Not only do these deals meet our quality and key market characteristics, but they are also accretive to our cost of capital on day one, based solely on the economics of the property.In addition, we expect to see between 25 basis points to 35 basis points of incremental yield when the assets are added to the platform. This is critical as we focus on driving overall performance to the bottom line. In Q3, we closed on acquisitions of approximately $135 million at an average cap rate just over 5.6%. This brought our acquisitions for the year up to $228 million at an average cap rate of 5.75%. This is before we add any incremental property savings from our platform, which should bring yields over 6%. These properties are located in our key markets including our new market of Boise, Idaho and we're 91% occupied as of closing. Approximately, 71% of these transactions are located on or adjacent to hospital…

Thanks, Caroline. From a financial and capital markets perspective, we had a very active quarter, capitalizing on opportunities to invest in accretive acquisitions and developments, refinance near term maturities at attractive rates and raise equity efficiently to preserve our balance sheet strength and remain active in pursuit of our growth opportunities. We also saw our year-to-date investments and operating performance fall to the bottom line and lead to a third quarter in a row of sequential earnings growth.Turning to the specific financial results, third quarter normalized FFO per diluted share was $0.42, up 5% for the first quarter of the year, as we continue to generate same-store growth and close on our acquisitions, redeploying capital raise in last year's Greenville sale into better assets and markets. Funds available for distribution increased to $17.9 million, which includes $17 million of recurring capital expenditures in the seasonally high third quarter, or approximately 14% of NOI. Our run rate for the year, however remains around 12% of NOI. G&A for the quarter was $9.7 million with the year-over-year increase driven primarily by the expensing of internal leasing in which we had capitalized $1.5 million in the year ago period. We continue to expect our G&A run rate to go run between $10 million and $11 million through rest of the year. This remains extremely efficient relative to our peers.As Scott and Caroline noted, we are seeing many new opportunities to invest in assets that will be accretive to our cost of capital. With our equity trading at implied cap rates in the low-5s, debt in the low 3% range and acquisition opportunities yielding over 6% once we add in our platform synergies. We will continue to be very active in our pursuit of these opportunities and raise the capital as we go to…

Thank you, Robert. And we'll open it up for questions.

We will now begin the question-and-answer session. [Operator Instructions] Our first question comes from John Kim with BMO Capital Markets.

Thank you. Scott, you mentioned on the redevelopment projects that you expect 10% to 12% returns. Can you just elaborate, is that a cash-on-cash development yield or is that more of an IRR concept?

I'll let Robert go ahead and talk through that. I think we said 8% to 12%, but...

Yes, John, we're really looking for 8% to 12% returns on that and that's a cash-on-cash return on that.

So in your current project that you are just modernizing and then re-tenanting, multi-tenanting the space or are you adding any leasable square footage?

It's a little bit of both, but the majority of it is just really modernizing the existing space, taking some master lease spaces that were much larger allowing for some smaller spaces and moving what we think are better equipped long term tenants into the spaces. I think, medical office is going through its middle innings right now of physician groups, healthcare systems, even academic university initiatives to determine where they want to be and what type of space they want, we're seeing as we've talked about the last three, four quarters, larger spaces being utilized.We've seen as Amanda pointed out, pre-leasing that was expiring in 2021, 2022 our folks have come forward and looked for extensions to opt to extend the lease but also to add improvements to the space. So this is really in line with what we would look for as a portfolio objective, which is over the next 18 to 24 months really putting in place what we think is a long-term rent escalators for our space, but also the right tenants that are going to be there and continue to be there for three or four iterations of their lease.

Okay. And my second question is on your different portfolio occupancy, which attributed to I think improving your tenant quality and also due to expirations, I'm wondering how much is left as far as the tenant's improvements is concerned. And then looking forward, you have about 10% to 11% of re-lease expiring per year. So are we going to see a noticeable improvement in occupancy in the near future?

I'll take that from a top level. I think we're very fortunate actually in 2019. We've been able to, this quarter, get active in our acquisitions, fill in our markets, which we purposely took up to the breadth last year based upon wanting to get our leverage in place, making sure that we felt comfortable with accretive investments and being able to put our asset management program in place with our engineering and services that we're providing now to the majority of the buildings. I think that we see from where we look at right now, continued occupancy gains from here. I think that we've taken a specific management decision process of, if you talk about first question redeveloping some space. I think every portfolio in America has some space that has been 15, 20, 30 years old and has been maintained or occupied by the original tenant. You need to go forward and change that space out, improve rents, get the correct escalators in place and we really took 2019 to try to go through that process and I think as we move into 2020, we're looking for some occupancy increase, some continued rent increases and again focused on escalators for the long-term five, seven, 10 year leases.I'll let Robert add anything else.

Yes. I think from like you know -- from a role perspective, we're pretty comfortable that we're working in this quarter and in the last couple of quarters on a couple of specific scenarios. That's going to continue to happen, but we don't see that as a material reduction in our occupancy. I think you've seen this come down a little bit here and I think you'll see us look to regain that in the first half of next year certainly, looking to grow it by the end of 2020.

So is it fair to assume that you expect an improvement in same-store NOI growth as well?

Well, I think from a leased rate perspective, I think that always kind of follows the -- the NOI follows the leased rate and the occupancy after that. So I think you'll see us look to get into next year in the 2% to 3% range. And then as occupancy increases then you'll see the NOI growth kind of follow suit after that.

Great, thank you.

Our next question comes from Chad Vanacore with Stifel.

Good morning. This is Seth Canetto on for Chad. The first question I had, I just wanted to touch on the acquisition pipeline and the pace of acquisitions this year, you know in the first half, you guys had stated that it would be back half weighted and here we stand today with you guys closing a significant amount of deals and increasing that for 2019. So how should we be thinking about the pipeline going forward, and just what had changed in the environment from the first half till now?

Well, obviously, we've always put shareholder value first, and that means accretive acquisitions. We've also said for many years now that we like the key market concept, and so we've been focused on the right timing as a company, we found that the second half of this year, we've started seeing opportunities that really fit in our portfolio. As Robert pointed out in his remarks, we see that it is accretive. We were fortunate to be able to match funding, so that we feel very comfortable that we can continue to grow earnings. And if you heard our first call, as we talked about at the beginning of the year, we've now been third year from the Duke transaction.We've certainly continued to grow earnings as we talked about with that portfolio, we've integrated it throughout the portfolio. And our focus is really shareholder value continuing to invest in our markets, and really taking advantage and of the right timing to do that and we're seeing opportunities. This has been a very fortuitous time for us, and we continue to see opportunities. And I don't like to talk about the future because you really don't know, but I think we will continue to see opportunities in our markets and we will take advantage of those as long as it's accretive to us and we find them in the markets that we like.

All right. And just continue on that path, are you seeing any large deals out there, and I know you mentioned the pricing for large deals remains competitive. So should we still expect you guys to do a lot of deals in the $25 million to $35 million range. It seems like you're kind of in that 5.6% to 5.75% yield, is that correct?

Well, we certainly like the 5.5% to 6.5% again. We've also looked at some assets that aren't 100% occupied. We bought some assets here recently, 85%, 90% occupied, being able to bring our leasing expertise and our management team to in that market to bear on the asset. Larger portfolios are certainly here recently in certainly in the last three quarters in 2019, maybe the end of 2018, a highly sought after by a multitude of different investors and some folks have paid very, very what we would consider very high prices for not as quality of assets as you would like to see or that you'd would like to acquire. Our focus has been not on buying something in looking at the first year NOI, of course we do that, but we want to make sure that we see consistent escalators, consistent occupancy and a five to seven year pathway that says that this asset is going to continue to drive NOI at the asset not be flat or potentially face issues where they are over market. We've seen some assets, we've seen some portfolios where I personally have felt that the rents in place are over market and that when come roll over time, there may be some issues and when that happens, we pass.

Got it, thanks for the color. And then re-leasing spreads have been really strong over the last year, they did decelerate a little bit to 2.7% in the quarter, is that sort of the run rate we should think of going forward for that metric?

Well, I think we've seen some strength in 2019 for rent growth and I think you'll continue to see it this year. We're already in the fourth quarter and from what we can see in our leasing pipeline, we're pretty happy with where we are with renewals that Amanda mentioned that we're in the process of -- as we rolled over the larger amount of the portfolio, it takes us a longer especially when you're dealing with healthcare systems or dealing with larger physician groups. I don't know, 2020, I think that if I was to say it in 2020, I think if you can get somewhere in the 2% range you may be looking at probably a pretty good indication of good solid space, a good asset and a good relationship with the tenant. I think that as we look forward into 2020, we may be seeing some slowing in the economy and if that happens, then medical office is such a safe space, but it is not immune to the influences of the general economic environment. So I would say that this has been a very good year for the MOB space.

Alright, great. And then just last question from me, looking at the Same Property Cash NOI guidance. I understand that you guys tightened that range 2.4% to 2.8%, implying 2.6% the midpoint. But year-to-date, you've done 2.7%. So is that slight downward revision at the midpoint due to the lower occupancy or how should we think about that?

I'll let Robert answer that.

Yes, I don't think there's any real change in outlook for us. I think when we said start of the year we thought we'd be 2% to 3%. I think we continue to think 2% to 3% is the right range for any given quarter depending on rollover and whatnot that's taking place. And so it's just largely the reflection of where we are to-date.

All right, great. Thanks for taking my questions.

Our next question comes from Nick Joseph with Citi.

Thanks. Maybe, following up on one of those questions. What differences are you seeing in terms of the buyer pool in cap rates between portfolio deals of one-off properties?

Well we've always built, except for the Duke transaction, we've built in the last 12 years through one-off acquisitions. We were fortunate to be able to define our markets and early on trying to get a some depth in the markets and some market knowledge. Our leasing folks have been with us primarily five, six, seven, eight years, and they get relationships within the market. Our acquisitions, we have always been active. So we like frankly, the one-off deals, because you know what you're getting, you get to blend that asset into the portfolio, and you don't pick up what could be troubled assets along with it. I think the pricing is more favorable. You've seen that I think from us, and I think from others that have bought one-off assets and if we can continue to articulate our game plan and our strategy, I think we can be successful. I wouldn't expect us to be in the hunt for larger portfolios just because there is that capital out there that seems to be extremely aggressive, and I think we want to make sure that we are accretive in our acquisitions, we want to grow earnings, we don't want to go backwards in any particular year based upon decisions made in prior years, and so we're going to be very conscious of how we spend shareholder capital.

Thanks. If you have to quantify it, would you say it's about 50, 75 basis points spread between where you can execute on the one-off versus where you've seen some of these portfolios trade?

I think that's a good general statement, but I would -- I actually think that if you look at the quality of the assets, vis-a-vis the cap rate spread, it's even wider, and I'm talking about performance. I'm talking about not just buying it today and saying it's 50, 75, 100 basis points. But okay what's it going to do in year 2, 3, 4 and 5, and how much capital do you have to put in the assets and our rents over market when they roll. I think it could be wider than that and we'll see as we go through the next two or three years from folks who have bought portfolios, and bought assets and the whole key and the whole processes can you consistently grow earnings year over year over year over year without having a period of time where you have to retrench or divest of things which are dilutive.

That's helpful, thanks. And then you've been using the forward [indiscernible] to match on the external growth, how do you think about the timing and execution of both issuing the equity and then ultimately settling it versus where the deals are in the pipeline and ultimately closing and spending the cash?

Well, I think from a -- I will answer that reverse where I think from a settlement perspective, one of the reasons we use it on a forward basis is so that we can take the cash when we actually close the transactions. We've had a philosophy along the way, since we came public in 2012 that we will really look to finance our acquisitions at the time we closed them or it's closed, they're about to do that. Some are forward basis, we issue it and then we'll take it down as we close the transaction. So we'd anticipate with the fourth quarter, specifically that we close our guidance indicates, another $150 million to $200 million and we'll look to take down most of that equity by the end of the period.

Thanks.

Our next question comes from Tayo Okusanya with Mizuho.

Yes, good morning you, guys. And congrats on a solid quarter.

Thank you.

My question has to do more around development and redevelopment. From a development perspective, I kind of recall a year ago, you guys talking about expectations of seeing increased demand from physicians and as also from hospital systems, and you kind of put out a number back then of hoping to kind of see the $100 million or so, anywhere from zero to $100 million in development starts and you kind of just announced $90 million. Caroline just talked about a number of $100 to $200 million hopefully as a new target. I'm just kind of curious, is it fair to kind of say you are seeing more activity from the hospital systems and that you really kind of, do you see development as being a bigger part of the growth engine over the next few years.

I'll do it, Robert just did, I'll take the last question first and then get to the second one. I do, I do think that HTA needs to have development as a fair part of its growth. I don't want it to be over-leveraged, I don't want it to be under leveraged. But I think that $100 million to $200 million is where we looked at it and we've taken some time to implement our team, we've taken some time to get out and introduce ourselves. We've taken some time to fight the interference that came with the Duke acquisition and it's a tough environment. I mean it's, when you're going after development deal, it's sort of like a football game.There is all different sides and you go in and you make your best pitch and we've been fortunate, we've been able to find some development that is occupied as we've talked about, we see some more. We're able to do some things that are already that we already control, which I think will help us over the coming quarters. And we've also been out looking for deals that I would say are on unattached work or just new opportunities with HTA, its development team, the management team, the leasing relationship we have with that particular opportunity. And so, yes, it is something that when we bought Duke, I didn't frankly, appreciate the opportunities that are presented. But certainly now that I've seen the integration between development, leasing, acquisitions, and relationships with healthcare systems and physicians, I think it was very, very fortunate that we were able to do the Duke transaction but also have as part of that transaction of the opportunity to focus on development.So we're very -- I think we're very happy about where we are. I'd like to see it improve and increase, and from a management perspective, we're certainly focused on that.

Got you. And then on the re-dev side also, could you talk a little bit about kind of opportunities you're looking at in your portfolio, how much of a re-dev you think you could be doing on an annualized basis. More importantly, as a result of re-dev maybe any kind of impact it could have on near-term NOI as you kind of empty out spaces to get them redone.

Right. I'll let Robert handle that.

Yes, I think as we look at redevelopment, we typically, I think as we go through our portfolio, we probably have three or four assets a year that we can look at as going through this process. I think Mission Viejo is really down the middle of the fairway for what we'd be looking to do, I mean this is a great fee-simple asset and probably one the most high demand areas in the country at least in our portfolio. And we've got the ability to take a 1970s vintage building that's largely been occupied by the hospital the entire time take what would be $25 renewals at a campus that's closer to $35 to $40 net rents. And so as we look at that, you put in $100, $125 a foot is pretty attractive returns cash-on-cash. As we look at the opportunity set there, there's probably three or four that we look to do a year. I don't think it's a significant drag as we look to it. It's one or two pennies a year, but I think that's been really how we've been running it over the last couple of years anyways. This just makes it more of a formalized program where the incremental capital really makes a big difference.

Just to kind of conclude what Robert was saying, when we did the Greenville transaction last year, we took their proceeds, we buy with a great transaction for shareholders. We held on to the proceeds, didn't match them as quickly as perhaps. At the time, we're very competitive environment, we didn't want to overpay for assets. One of our focuses as we came into 2019 moving to 2020-2021 is continued earnings growth. Our focus is not to take properties out of production, so to speak, simply to put capital into them. We want to make sure that we're focused on shareholder value and continue to move our earnings quarter-over-quarter.

Excellent. I'm liking your comments about better internal and external growth and it's good to see that starting to happen. So congratulations.

Thank you.

Our next question comes from Connor Siversky with Berenberg.

Hi, guys, and thank you for taking my question. Just to piggyback off the previous one, we noticed an increase in recurring CapEx, specifically in second generation tenant improvements. Can we expect these elevated levels to go forward or maybe a reversion to a historical mean?

As we look at our capital and our TI, it certainly does follow from a leasing perspective. So second generation TIs was a little bit higher. I think it comes down slightly from where we were in third quarter. I think is important to remember, third quarter is almost always our highest capital period just from a weather perspective and for whatever reason, it matches up with some of the leasing trends. So we would expect a recurrent capital overall to decrease a little bit. I think as we look at the long term outlook, it's probably still in the 12% to 13% of that NOI range. So third quarter certainly elevated above where we see that playing out over the long term.

Okay, thanks for that. And then maybe one more for me. In terms of these development stats $100 million to $200 million year-over-year, do you see that at the top of your capacity or if not what kind of limiting factors do you guys run into that would increase that level?

Well, I think that the capacity from an internal perspective and from an organizational is not a limit. I think that we are staffed and have the ability and we've really got to put together what we think now is a very solid team. We've made presentations. We've been through the fire, so to speak of the exchange between information and so forth so it's not a capacity issue. I do think, though, that we want to keep it in moderation. Medical office is somewhat different than any other development because typically medical office needs to be occupied. At least our philosophy is it needs to be 70%, 80% pre-leased. It needs to be leased for the credit. It needs to be something that when it's built, they move in and so you don't have that risk, so to speak of, well, gee whiz, we hope we're going to find the tenants. So we want to keep it balanced as far as our mix as a company. Right now for our size and for where we are, I think $100 million to $200 million is probably one very achievable, which is important, but also it probably represents where the sector is from a development perspective. We're not going to win them all. We're not going to go after them all. We're not going to have all the relationships that some other folks have and we have some. So when we look at what we can do and how we think we can perform, I think for the next 12 to 18 to 24 months, if we continue to do that $100 million to $200 million, I think that will be a very good starting point as this process continues in the medical office sector of either redevelopment of space that's there or new development from healthcare systems for particular new assets.

All right, great, that's all for me. Thank you.

Our next question comes from Todd Stender with Wells Fargo.

Thanks. Just back to the capital sources, I guess with the 6 million shares that you've gotten the proceeds or you are about to through the forward ATM that will essentially fund the incremental acquisitions you've announced. But you also had guided for some dispositions to occur in Q4. Are those still other sales still happening?

I think as we look at our dispositions, we certainly do have several properties that we're in the process of disposing. I think we've been out of the market with those and we do have offers on the table and so you will probably see us close a couple of those in the fourth quarter. It's going to be the amount is -- I don't think we've changed our expectation on that but it could be anywhere from probably $10 million up to the full $75 million we had guided to. It's just a matter of how it goes through the process. That said, I think as we look at our disposition program, and how we will utilize dispositions, it'll largely go to fund incremental acquisitions. So as we look to dispose properties we'll look to have the incremental acquisitions on top of them to quickly recycle the capital, really outside of the one-off markets that we find ourselves in and put them into the markets that are more core for HTA long term.

Thanks, Robert, just sticking with you. Do you need more capital over the near term? The ATM that you sold the 6 million shares I gather the share price was $29. Your stock is now over $30. How are you looking at maybe going through just your standard ATM or maybe you don't need the proceeds right now?

I think as we look at our balance sheet is in great shape. One of the things that we liked about being able to utilize the ATM in this way was it really did match fun things as you point out and so anytime from here the balance sheet is in a perfect position. I think anything as we look to go forward, we got to find great deals and I think great deals is just a good thing for shareholders and at the appropriate time, we will look to come back for equity or dispositions as appropriate.

I think, Todd, I think we want to be very selective. We want to continue to focus on earnings. We want to continue to focus on shareholder value. And as Robert said, we want to make sure that we're finding good assets, which we're seeing right now in our markets, which is also appropriate. But we want to be very conscious of earnings growth, match funding, and being very conscious of generating shareholder value.

That's helpful. And then just switching gears back to the Mission Viejo redevelopment project. Just for clarification, I think you mentioned that some of the leases are expiring in the 2021 era. I would imagine that you'd let some of these leases expire so the tenants can move out. Maybe just kind of clarify what the timing looks like for some of those leases to expire, when you're going to break ground and maybe when we start to see some of those 8% to 12% returns. Thanks.

Mission Viejo, the tenants actually largely moved out in the middle of the third quarter on that. So that was reflective of a bit of our overall occupancy decline, a significant portion of that. So we should see that start to re-lease. I think as Amanda noted in her comments we should see it start to lease-up. We'll complete most of the modernization by the second quarter of 2020 and see it lease-up by the end of the year is our expectation.

We were very excited about that asset. Great location as you know being from the West Coast and actually being in that area. We saw that campus much like we saw Forest Park when we -- even though we didn't anticipate the transition that Forest Park went through with HTA but we did think that this is a great campus. Has got long term value and frankly, probably not better real estate in our portfolio company-wide so we're excited about putting the dollars in there and then starting to see in end of 2020. 2021 started to see the benefits of the rent increases and the occupancy back up to 95%.

All right, thanks, guys.

Our next question comes from Michael Mueller with JPMorgan.

Hi. Most things have been answered. But just on the prior question, the modernization. Can you talk a little bit about what goes into modernizing a building as opposed to besides doing lobbies, elevators, just changing the space around for different types of uses? Just what's the scope of it? What's going on there?

Well, I think you just did our answer. It's obviously HPAC, it's elevators, the lobbies. Tenants when they walk into buildings now they want to have a nice or what I would call a lighted type of experience where they're not walking into something that's 30, 40 years old. I mean, ceiling heights are also part of the equation. Making sure that the space is laid out so that the appropriate tenants are in the appropriate places. I think that's a big thing that Amanda and her team is focused on. Is putting tenants where they need to be for long term occupancy because some need first-floor space, some need exposure, some don't and we're putting that in our leasing plans and looking at how we roll this space out. Again, I look at this space now, you remodel it, you put some dollars into it, you move the rents up, you get occupancy, and then you're set for the next 15, 20 years. Again, this is really good real estate and to maximize that is just a real benefit for shareholders.

And just to add a little bit of color to that, I think some of the most important things that we're looking at are things that we can do to the building that'll expand the type of tenants that we can put in. Things like the spring cleaning up the building, or as Scott mentioned, the raised ceiling heights or Gurney elevators, ADA upgrades. All of those things that we're doing will now allow us to lease our space to a whole different tenancy set. So those are the kind of things that we're looking for.

Got it. That's helpful. Thank you.

Our next question comes from Lukas Hartwich with Green Street Advisors.

Thanks. Good morning. Just one for me. I'm curious when you're talking to sellers, how often do OP units come into the conversation?

Well, we had the opportunity. Our acquisition in Boise and that was one of the reasons that we've always liked that market and it was an opportunity to align ourselves with someone who's been in the market a long time, good asset, good location. And that was something that we really liked. We did that on the East Coast. We did a transaction in Connecticut, where folks took a lot of OP units, and that was one of the reasons that we liked that portfolio so well. Frankly, it's performed very well and knock on wood, they've done well with us. So we like OP unit opportunities when we see them. I think you'll see more of those. We certainly talk about it and I know our peers talk about it because the tax impact of folks who have had property for such a long time. They don't want to pay the taxes. They don't necessarily want to do a 1031 again so we have that conversation. But I would not say that we've seen or at least I have not seen a tremendous amount of that over the last 18 months.

Great, thank you.

Our next question comes from Daniel Bernstein with Capital One.

Good morning. Now that you're doing redevelopment in your own portfolio, what are the value add opportunities you're seeing on the acquisition side? Is there some limiting factor in terms of the property age or how much you want to modernize or bring on to the portfolio to modernize, or is it just a matter of price? Just trying to understand if there's a lot of value add opportunities out there or there's some other limiting factors for you.

As I mentioned earlier, we acquired some assets with some occupancy upside. That's very good for us. Number one, is accretive what we pay for with existing NOI; but number two, we get to bring our leasing teams and we get to bring some increased NOI. I think that's part of our focus on earnings growth. Buying buildings that need a substantial amount of modernization probably is not something that we would do. Typically those assets are much, much older. They're smaller. They're not necessarily in our key markets. I would make an exception for that, for example, Boston has gone through renovations and we've had some opportunities and are actually -- hopefully, have opportunities to do something like that there but that's what the healthcare system. It's with some buddy that has a specific use. And yes, it will take some capital, but it's already pre-leased in their mind, and it's got a great location. But you need to be careful about the market. I think we're not looking to do secondary markets. We're not looking to do markets outside the 15% to 20% that we like. So that's where I would say that our focus is. Moderate is good. Significant is probably not where we are.

That's all I had. Thanks.

This concludes our question and answer session. I would now like to turn the conference back over to Scott Peters for any closing remarks.

Well, thank you, everybody, for joining us. And we'll look forward to seeing our investors at Neary [ph]. Again, thank you and any questions please call Robert or myself and we'll get back to you. Thank you.

The conference has now concluded. Thank you for attending today's presentation. You may now disconnect.